Tiny but Mighty: Sophisticated innovation for early-stage research
The 0.5 m² scale-X™ nexo bioreactor redefines what’s possible in early-stage research – delivering premium sophistication in a compact design. Its scalable platform seamlessly supports direct scale-up to 600 m² with minimal adaptations, ensuring a smooth, accelerated, and low-risk process from small to large-scale production.
FEATURES
Click & Learn
A solution for early process development
Take your scale-X nexo system
to the next level
Compatible with the Skaia™ vision software for advanced cell monitoring and prediction, the scale-X nexo bioreactor delivers unmatched performance for fast, reliable, and scalable bioprocessing.
Benefits
Reduce costs per run by up to 60%1
Reach cost-effective bioprocess development with this small-scale, low-footprint scale-X™ nexo bioreactor system. Developed for early-stage screening and research, the bioreactor allows cells to grow on a surface of 0,5 m2 in a volume of only 75mL. Such miniaturization reduces the consumption of media, reagents, and seed-train efforts. Combined with high-value consumables, this results in significantly lower cost per run.1
Accelerate your path to market with seamless scalability
Develop your bioprocess effortlessly from research to commercial manufacturing in the same platform. Scalable by design, the technology enables quick transition between scale-X nexo (0,5 m²), scale-X carbo (10-30 m²) and scale-X nitro (200-600 m²) bioreactors. By maintaining homogeneous cell distribution, high cell density and productivity across scales, accelerate time to market with fewer runs, reduced time and minimized effort.
Rely on ready-to-use consumables for struggle-free operations
Eliminate preparation steps while minimizing contamination risk thanks to gamma-irradiated, single-use consumables. The intuitive design of the manifolds ensures rapid set-up and quick-start of your experiments. Liquid sampling and easy retrieval of the fixed-bed enable monitoring and precise cell counting, ensuring stress-free R&D and creating the basis for a process without surprises.
Key applications
Viral vectors for cell and gene therapy
Viral vaccines (human & veterinary)
Oncolytic viruses
Exosomes
Downloads
Related Publications
Interested in the
scale-X™ nexo system?
- Based on Univercells Technologies’ internal data comparing the scale-X nexo bioreactor system to entry-level fixed-bed bioreactors from competitors. The reported savings of up to 60% may vary depending on specific process conditions, bioreactor configurations, and operational practices. Actual results will depend on the user’s workflow and setup. ↩︎
- Based on Univercells Technologies’ internal data comparing the scale-X nexo bioreactor system to entry-level fixed-bed bioreactors from competitors. The reported savings of up to 60% may vary depending on specific process conditions, bioreactor configurations, and operational practices. Actual results will depend on the user’s workflow and setup. ↩︎